Burkholderia pseudomallei: Difference between revisions
From IDWiki
Burkholderia pseudomallei
m (Aidan moved page Burkholderia pseudomallei (melioidosis) to Burkholderia pseudomallei without leaving a redirect) |
No edit summary |
||
Line 1: | Line 1: | ||
= ''Burkholderia pseudomallei'' (melioidosis) = |
= ''Burkholderia pseudomallei'' (melioidosis) = |
||
− | + | = Microbiology = |
|
* Oxidase positive, indole-negative Gram-negative rod with "'''safety pin'''" appearance |
* Oxidase positive, indole-negative Gram-negative rod with "'''safety pin'''" appearance |
||
* Non-hemolytic |
* Non-hemolytic |
||
− | + | = Epidemiology = |
|
* Humans and animals |
* Humans and animals |
||
Line 23: | Line 23: | ||
** Thalassemia |
** Thalassemia |
||
− | + | = Clinical Presentation = |
|
* Incubation period 9 days (range 1 to 21 days) |
* Incubation period 9 days (range 1 to 21 days) |
||
Line 35: | Line 35: | ||
* About 20% of clinical cases with develop septic shock |
* About 20% of clinical cases with develop septic shock |
||
− | + | = Diagnosis = |
|
+ | * Culture |
||
− | <ul> |
||
⚫ | |||
− | <li><p>Culture</p> |
||
+ | ** Grows on blood agar, MacConkey, etc. (i.e. ''not'' a fastidious organism) |
||
− | <ul> |
||
⚫ | |||
⚫ | |||
− | + | ** On sheep blood agar, grows as small, smooth, cream-coloured colony with metallic sheen |
|
⚫ | |||
− | <ul> |
||
⚫ | |||
⚫ | |||
⚫ | |||
− | </li> |
||
+ | ** PCR |
||
− | <li>On sheep blood agar, grows as small, smooth, cream-coloured colony with metallic sheen |
||
⚫ | |||
− | <ul> |
||
⚫ | |||
⚫ | |||
− | </li></ul> |
||
− | </li> |
||
⚫ | |||
⚫ | |||
− | <ul> |
||
− | <li>PCR</li> |
||
⚫ | |||
⚫ | |||
− | + | = Management = |
|
⚫ | |||
− | <ul> |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
+ | * TMP-SMX |
||
⚫ | |||
− | <li>TMP-SMX</li></ul> |
||
− | + | = Biosafety = |
|
⚫ | |||
− | <ul> |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
− | <ul> |
||
⚫ | |||
⚫ | |||
+ | |||
− | </li> |
||
+ | {{DISPLAYTITLE:''Burkholderia pseudomallei''}} |
||
⚫ | |||
+ | [[Category:Gram-negative bacilli]] |
||
− | <ul> |
||
⚫ | |||
− | </li></ul> |
||
− | </li></ul> |
Revision as of 21:29, 14 August 2019
Burkholderia pseudomallei (melioidosis)
Microbiology
- Oxidase positive, indole-negative Gram-negative rod with "safety pin" appearance
- Non-hemolytic
Epidemiology
- Humans and animals
- Important cause of death in SE Asia and northern Australia
- Up to 80% seroprevalence in Thailand, mostly asymptomatic
- Sporadic cases elsewhere
- May have latent disease with reactivation much later
- Acquired by percutaneous inoculation, inhalation (esp. lab workers), and ingestion
- Risk factors for clinical disease
- Diabetes
- Heavy alcohol use
- Chronic lung disease
- Chronic kidney disease
- Treatment with glucocorticoids
- Cancer
- Thalassemia
Clinical Presentation
- Incubation period 9 days (range 1 to 21 days)
- Presentations can vary from asymptomatic, skin ulcers, abscesses, latent infection, chronic pneumonia (similar to TB), or fulminant shock
- Pneumonia (50%)
- GU infection (15%)
- Skin (15%)
- Primary bacteremia (10%)
- Septic arthritis/OM (3-5%)
- Neuro (3-5%)
- About 20% of clinical cases with develop septic shock
Diagnosis
- Culture
- Blood, throat, and urine cultures from all patients with suspected melioidosis
- Grows on blood agar, MacConkey, etc. (i.e. not a fastidious organism)
- Can use selective colistin or polymyxin B
- On sheep blood agar, grows as small, smooth, cream-coloured colony with metallic sheen
- May develop a dry and wrinkled appearance after 1 to 2 days of incubation
- PCR
- Immunofluorescence and latex agglutination
- Serology (acute/convalescent)
Management
- Intrinsic resistance to many antibiotics, especially using efflux pumps
- Ceftazidime
- Amoxicillin-clavulanic acid
- TMP-SMX
Biosafety
- Lab workers can have aerosol exposure
- May need prophylaxis in high-risk patients
- Septra or doxy or amox/clav
- Needs to be sent to CDC via NML
References
- ^ Bart J. Currie, Linda Ward, Allen C. Cheng. David Joseph Diemert. The Epidemiology and Clinical Spectrum of Melioidosis: 540 Cases from the 20 Year Darwin Prospective Study. PLoS Neglected Tropical Diseases. 2010;4(11):e900. doi:10.1371/journal.pntd.0000900.